Embracing Self-collecting cervico-vaginal Human Papilloma Virus testing for cervical cancer screening: An exploratory study of acceptability among women in Penang

Farah Amirah Fazida; Haoling Zhang; Haolong Zhang; Salina Sany; Doblin Sandai

doi:10.62051/ijphmr.v1n1.06

Authors

Farah Amirah Fazida
Haoling Zhang
Haolong Zhang
Salina Sany
Doblin Sandai

DOI:

https://doi.org/10.62051/ijphmr.v1n1.06

Keywords:

Cervicovaginal human papilloma, Virus detection, Cervical cancer screening

Abstract

Objective: This study aims to assess the acceptability and awareness of Penang women regarding self-collected cervico-vaginal specimens for HPV testing. Method: The study was conducted in Penang State throughout January to December 2020, in collaboration with the Penang West Hat Community Programme. The study's target population included women aged 25-60 from the Little Siradan, North West, Terenga, and Barat daya communities, who self-collected cervicovaginal samples using a cervicovaginal brush. Following sample collection, participants completed brief questionnaires to gauge their acceptance and perceptions of this self-sampling approach. They also received counseling and guidance at local health departments for Pap test follow-ups. Result: Vaginal microbiota examination revealed a significant correlation between baseline (W0) and twelve weeks later (W12) across various parameters, encompassing the Women's Health Questionnaire (WHQ), blood samples, fecal samples, distributed products to subjects, and vaginal samples (p < 0.001). Analysis of DNA concentration (VM) demonstrated a substantial difference in A260/280 ratios (p < 0.001), while A260/230 ratios showed no statistical significance (p=0.212). Additionally, the vaginal microbiome results displayed noteworthy distinctions between fecal and vaginal samples. Conclusion: The findings of this study hold promise for the initial community-wide implementation of HPV testing, which is anticipated to be introduced in Malaysia in the near future.

References

Chaban, B., Links, M. G., Jayaprakash, T. P., Wagner, E. C., Bourque, D. K., Lohn, Z. . . Hemmingsen, S. M. (2014). Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome, 2(1), 1-12.

Chong, G. O., Han, H. S., Lee, S. D., & Lee, Y. H. (2020). Improvement in RNA quantity and quality in cervico-vaginal cytology. Virology journal, 17, 1-7.

Eprikyan, E., Yureneva, S., Donnikov, A., & Ezhova, L. (2019). Relationship between the symptoms of vulvovaginal epithelial atrophy and the vaginal microbiota in postmenopausal women. Obstetrics and Gynecology, 11, 152-159.

HOCK, T. (2017). SINGLE NUCLEOTIDE POLYMORPHISMS OF p53, p21, CYP1A1, FAS, AND BENZO (α) PYRENE AS RISK FACTORS IN CERVICAL CARCINOMA.

Jacobs, M. V., Walboomers, J. M., Snijders, P. J., Voorhorst, F. J., Verheijen, R. H., Fransen-Daalmeijer, N., & Meijer, C. J. (2000). Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. International journal of cancer, 87(2), 221-227.

Momenimovahed, Z., Mazidimoradi, A., Amiri, S., Nooraie, Z., Allahgholi, L., & Salehiniya, H. (2023). Temporal trends of cervical cancer between 1990 and 2019, in Asian countries by geographical region and socio-demographic index, and comparison with global data. Oncologie, 25(2), 119-148.

Mustafa, W. A., Ismail, S., Mokhtar, F. S., Alquran, H., & Al-Issa, Y. (2023). Cervical Cancer Detection Techniques: A Chronological Review. Diagnostics, 13(10), 1763.

Pan, Y., & de La Puente, M. (2005). Census Bureau guideline for the translation of data collection instruments and supporting materials: Documentation on how the guideline was developed. Survey Methodology, 6.

Perkins, R. B., Wentzensen, N., Guido, R. S., & Schiffman, M. (2023). Cervical cancer screening: a review. Jama, 330(6), 547-558.

Prince, A. L., Antony, K. M., Chu, D. M., & Aagaard, K. M. (2014). The microbiome, parturition, and timing of birth: more questions than answers. Journal of reproductive immunology, 104, 12-19.

Raub, S. H. A., Isa, N. M., Zailani, H. A., Omar, B., Abdullah, M. F., Amin, W. A. M., . . . Kassim, F. (2014). Distribution of HPV genotypes in cervical cancer in multiethnic Malaysia. Asian Pacific Journal of Cancer Prevention, 15(2), 651-656.

Sainei, N. E., Kumar, V. S., Chin, Y. S., & Salih, F. A. (2018). High prevalence of human papillomavirus types 56 and 70 identified in the native populations of Sabah, Malaysia. Asian Pacific Journal of Cancer Prevention: APJCP, 19(10), 2807.

Shardell, M., Gravitt, P. E., Burke, A. E., Ravel, J., & Brotman, R. M. (2021). Association of vaginal microbiota with signs and symptoms of the genitourinary syndrome of menopause across reproductive stages. The Journals of Gerontology: Series A, 76(9), 1542-1550.

Wang, X., Huang, X., & Zhang, Y. (2018). Involvement of human papillomaviruses in cervical cancer. Frontiers in microbiology, 9, 2896.

Wong, L., Wong, Y., Low, W., Khoo, E., & Shuib, R. (2009). Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore medical journal, 50(1), 49.

Zaridah, S. (2014). A review of cervical cancer research in Malaysia. Med J Malaysia, 69(Suppl A), 33-41.